Search

Your search keyword '"Glisson, Bonnie S."' showing total 16 results
Start Over Author "Glisson, Bonnie S." Publisher j.b. lippincott company
16 results on '"Glisson, Bonnie S."'

1. Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma

Author

William, William N., Jr., Uyeki, James, Johnson, Faye M., Feng, Lei, Peeples, Beverly O., Fossella, Frank V., Karp, Daniel D., Blumenschein, George R., Stewart, David J., and Glisson, Bonnie S.

Subjects
Lung cancer, Small cell -- Care and treatment, Lung cancer, Small cell -- Research, Chemotherapy -- Methods, Chemotherapy -- Research, Cisplatin -- Dosage and administration, Cisplatin -- Research, Etoposide -- Dosage and administration, Etoposide -- Research, Cancer -- Chemotherapy, Cancer -- Methods, Cancer -- Research, Health
Published
2010

2. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study

Author

Thariat, Juliette, Ahamad, Anesa, El-Naggar, Adel K., Williams, Michelle D., Holsinger, Floyd C., Glisson, Bonnie S., Allen, Pamela K., Morrison, William H., Weber, Randal S., Ang, K. Kian, and Garden, Adam S.

Subjects
Head and neck cancer -- Patient outcomes, Head and neck cancer -- Research, Squamous cell carcinoma -- Patient outcomes, Squamous cell carcinoma -- Research, Radiotherapy -- Patient outcomes, Radiotherapy -- Research, Health
Published
2008

3. Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up

Author

Thariat, Juliette, Ahamad, Anesa, El-Naggar, Adel K., Williams, Michelle D., Holsinger, Floyd C., Glisson, Bonnie S., Allen, Pamela K., Morrison, William H., Weber, Randal S., Ang, K. Kian, and Garden, Adam S.

Subjects
Ovarian cancer -- Care and treatment, Ovarian cancer -- Patient outcomes, Ovarian cancer -- Research, Cancer patients -- Prognosis, Chemotherapy -- Patient outcomes, Chemotherapy -- Research, Injections, Intraperitoneal -- Patient outcomes, Injections, Intraperitoneal -- Research, Cancer -- Chemotherapy, Cancer -- Patient outcomes, Cancer -- Research, Health
Published
2008

5. Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer

Author

Zinner, Ralph G., Fossella, Frank V., Gladish, Gregory W., Glisson, Bonnie S., Blumenschein, George R., Papadimitrakopoulou, Vassiliki A., Pisters, Katherine M.W., Kim, Edward S., Oh, Yun W., Peeples, Beverly O., Ye, Zhishen, Curiel, Rafael E., Obasaju, Coleman K., Hong, Waun K., and Herbst, Roy S.

Subjects
Lung cancer, Non-small cell -- Drug therapy, Carboplatin -- Research, Pemetrexed -- Research, Chemotherapy, Combination -- Research, Chemotherapy -- Research, Health
Published
2005

6. Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma

Author

Kim, Edward S., Kies, Merrill S., Fossella, Frank V., Glisson, Bonnie S., Zaknoen, Sara, Statkevich, Paul, Munden, Reginald F., Summey, Carmen, Pisters, Katherine M.W., Papadimitrakopoulou, Vali, Tighiouart, Mourad, Rogatko, Andre, and Khuri, Fadlo R.

Subjects
Chemotherapy, Combination -- Evaluation, Paclitaxel -- Evaluation, Lung cancer -- Drug therapy, Lung cancer -- Patient outcomes, Health, Lonafarnib (Medication) -- Evaluation
Published
2005

8. Is concurrent chemoradiation the treatment of choice for all patients with stage III or IV head and neck carcinoma?

Author

Garden, Adam S., Asper, Joshua A., Morrison, William H., Schechter, Naomi R., Glisson, Bonnie S., Kies, Merrill S., Myes, Jeffrey N., and Ang, K.Kian

Subjects
Radiotherapy -- Methods, Radiotherapy -- Evaluation, Head and neck cancer -- Care and treatment, Head and neck cancer -- Observations, Head and neck cancer -- Patient outcomes, Chemotherapy -- Methods, Chemotherapy -- Evaluation, Cancer -- Chemotherapy, Cancer -- Methods, Cancer -- Evaluation, Health
Published
2004

9. Management of Nonsinonasal Neuroenocrine Carcinomas of the Head and Neck

Author

Barker, Jerry L., Jr., Glisson, Bonnie S., Garden, Adam S., El-Naggar, Adel K., Morrison, William H., K. Kian Ang, K. S. Clifford Chao, Clayman, Gary, and Rosenthal, David I.

Subjects
Head and neck cancer -- Care and treatment, Head and neck cancer -- Research, Health
Published
2003

10. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma

Author

Papadimitrakopoulou, Vassiliki, Ginsberg, Lawrence E., Garden, Adam S., Kies, Merrill S., Glisson, Bonnie S., Diaz, Eduardo M., Clayman, Gary, Morrison, William H., Liu, Diane D., Blumenschein, George, Lippman, Scott M., Schommer, Donald, Gillenwater, Ann, Goepfert, Helmuth, and Hong, Waun K.

Subjects
Radiotherapy -- Methods, Cisplatin -- Research, Health
Published
2003

11. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma

Author

Herbst, Roy S., Khuri, Fadlo R., Lu, Charles, Liu, Diane D., Fossella, Frank V., Glisson, Bonnie S., Pisters, Katherine M. W., Shin, Dong M., Papadimitrakopoulou, Vassiliki A., Kurie, Jonathan M., Blumenschein, George, Jr., Kies, Merrill S., Zinner, Ralph, Jung, Maria S., Lu, Robert, Lee, J. Jack, Munden, Reginald F., Hong, Waun Ki, and Lee, Jin Soo

Subjects
Cancer, Gemcitabine -- Health aspects, Lung cancer, Non-small cell -- Care and treatment, Biological products -- Health aspects, Toxins -- Physiological aspects, Health
Published
2002

12. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

Author

Shin, Dong M., Glisson, Bonnie S., Khuri, Fadlo R., Lippman, Scott M., Ginsberg, Lawrence, Papadimitrakopoulou, Vassiliki, Feng, Lei, Francisco, Marites, Garden, Adam, Kies, Merrill S., Myers, Jeffrey, Clayman, Gary, Hong, Waun Ki, and Diaz, Edward, Jr.

Subjects
Cancer -- Research, Chemotherapy -- Health aspects, Paclitaxel -- Health aspects, Ifosfamide -- Health aspects, Carboplatin -- Health aspects, Squamous cell carcinoma, Head and neck cancer, Health
Published
2002

13. Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

Author

Tseng, Jennifer E, Glisson, Bonnie S, Khuri, Fadlo, Shin, Dong M, Myers, Jeffrey N, El-Naggar, Adel K, Roach, Jennifer S, Ginsberg, Lawrence E, Thall, Peter F, Wang, Xuemei, Teddy, Stephanie, Lawhorn, Kristie N, Zentgraf, Rebecca E, Steinhaus, Ganene D, Pluda, James M, Abbruzzese, James L, and Hong, Waun Ki

Subjects
Neovascularization -- Prevention, Thalidomide -- Health aspects, Head and neck cancer -- Metastasis, Squamous cell carcinoma, Vascular endothelial growth factor -- Measurement, Fibroblast growth factors -- Measurement, Health
Published
2001

15. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study

Author

Geara, Fady B., Glisson, Bonnie S., Sanguineti, Giuseppe, Tucker, Susan L., Garden, Adam S., Ang, K. Kian, Lippman, Scott M., Clayman, Gary L., Goepfert, Helmuth, Peters, Lester J., and Hong, Waun K.

Subjects
Nose cancer -- Care and treatment, Radiotherapy -- Usage, Chemotherapy -- Usage, Combined modality therapy -- Evaluation, Health
Published
1997

16. Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer

Author

Lee, Jin S., Libshitz, Herman I., Fossella, Frank V., Murphy, William K., Pang, Arlita C., Lippman, Scott M., Shin, Dong M., Dimery, Isaiah W., Glisson, Bonnie S., and Hong, Waun K.

Subjects
Lung cancer, Non-small cell, Health
Abstract

Although several combinations of chemotherapeutic agents have shown some effectiveness in the treatment of non-small cell lung cancer, none is clearly superior and none is satisfactory. One agent that shows promise in the attempts to develop new chemotherapeutic protocols for lung cancer is edatrexate. This drug is similar in chemical structure to methotrexate and operates by a similar mechanism. Edatrexate inhibits the enzyme dihydrofolate reductase, which plays an important role in the synthesis of some of the bases necessary for DNA. A study was conducted to evaluate the effectiveness of a chemotherapeutic regimen which includes the standard chemotherapeutic agents cisplatin and cyclophosphamide, and the experimental agent edatrexate. Thirty-two patients with advanced stage non-small cell lung cancer participated in the clinical trial; none had received any prior chemotherapy. The study began with the treatment of 16 patients with a total dose of 800 mg per meter squared (milligrams per square meter of body area) cyclophosphamide, 80 mg per meter squared cisplatin, and 80 mg per meter squared edatrexate. This protocol yielded two complete responses and five partial responses. An additional five patients had minor responses. However, this regimen was poorly tolerated, and many patients developed a serious suppression of bone marrow and inflammation of the stomach. The dosage was therefore reduced by one-eighth for the next 16 patients. This reduction in dose resulted in a reduction in effectiveness as well; no patients in the second group achieved a complete response; four developed partial responses. Patients who developed a complete or partial response had a median survival time of 55 weeks. The median survival of the patients with a minor response was 39 weeks. The remaining patients survived a median of 27 weeks. This study suggests that edatrexate improves the response to chemotherapy with cisplatin and cyclophosphamide. However, the response curve is steep, meaning that a slight change in dose results in a significant change in effectiveness. It may be possible to improve the success of the treatment regimen if ways can be found to raise the dose while minimizing the adverse side effects of stomatitis and myelosuppression. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results